Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Pharmacophore models can predict liver toxicity and central nervous system toxicity, but they have limitations and specific requirements.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Better hair loss models needed for research.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

Tea compound EGCG may slow aging by affecting gene activity.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Three compounds from Dadap leaves may help treat hair loss.

Adding a second method to PROTACs could improve cancer treatment.

The model and estimator can predict drug exposure in kidney transplant patients well.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Computational methods can speed up and improve the development and safety of herbal drugs.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

A new compound was effective for imaging prostate cancer in rats.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

SFE is a better extraction method, and the HPTLC method is effective for analyzing wedelolactone in E. alba.

Chemistry42 effectively creates and optimizes new molecules for drug discovery.

Multitarget drugs are needed to better treat complex diseases.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

These methods help understand cell structures and reactions.

Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.

Topical peptides may offer safer, effective pain relief and healing for wounds.